PatrickShawnTwomeyMDMBA

Internal Medicine • South San Francisco, CA

Clinical Pharmacology

Group Medical Director

Join to view full profile

Dr. Twomey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Twomey's full profile

Already have an account?

Office
1000 Gateway Blvd
building 40
South San Francisco, CA 94080

Education & Training

University of North Carolina, Kenan-Flagler School of BusinessMBA, Business, 2014 - 2016
National Capital ConsortiumFellowship, Clinical Pharmacology, 2011 - 2013
Tripler Army Medical CenterResidency, Internal Medicine, 2007 - 2010
Georgetown University School of MedicineClass of 2007
College of the Holy CrossBA, Chemistry/Biochemistry, Cum Laude, 1998 - 2002

Certifications & Licensure

VA State Medical License 2009 - 2024
CA State Medical License 2018 - 2021

Publications & Presentations

PubMed

163 citations
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study
Jason A. Regules, Susan Cicatelli, Jason W. Bennett, Kristopher M. Paolino, Patrick S. Twomey
The Journal of Infectious Diseases. 2016-09-01
270 citations
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report
Jason A. Regules, John H. Beigel, Kristopher M. Paolino, Jocelyn Voell, Amy R. Castellano
The New England Journal of Medicine. 2017-01-26
172 citations
Protection against Plasmodium falciparum malaria by PfSPZ Vaccine
Judith E. Epstein, Kristopher M. Paolino, Thomas L. Richie, Martha Sedegah, Alexandra Singer
JCI Insight. 2017-01-12

Press Mentions

Careers in Drug Safety with Dr. Patrick Twomey – Episode 110February 16th, 2023

Industry Relationships

Senior Medical Director, GenentechFull time employee.Disclosure: Portion of compensation in Roche stock grants2017 - Present